J
Jennifer Lee
Researcher at Harvard University
Publications - 126
Citations - 5282
Jennifer Lee is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 36, co-authored 102 publications receiving 4296 citations. Previous affiliations of Jennifer Lee include Howard Hughes Medical Institute & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program.
Derek Klarin,Derek Klarin,Scott M. Damrauer,Scott M. Damrauer,Kelly Cho,Yan V. Sun,Tanya M. Teslovich,Jacqueline Honerlaw,David R. Gagnon,David R. Gagnon,Scott L. DuVall,Jin Li,Jin Li,Gina M. Peloso,Mark Chaffin,Aeron Small,Aeron Small,Jie Huang,Hua Tang,Julie A. Lynch,Yuk-Lam Ho,Dajiang J. Liu,Connor A. Emdin,Connor A. Emdin,Alexander H. Li,Jennifer E. Huffman,Jennifer Lee,Jennifer Lee,Pradeep Natarajan,Pradeep Natarajan,Rajiv Chowdhury,Danish Saleheen,Danish Saleheen,Marijana Vujkovic,Marijana Vujkovic,Aris Baras,Saiju Pyarajan,Saiju Pyarajan,Emanuele Di Angelantonio,Benjamin M. Neale,Benjamin M. Neale,Aliya Naheed,Amit Khera,Amit Khera,John Danesh,Kyong-Mi Chang,Kyong-Mi Chang,Gonçalo R. Abecasis,Cristen J. Willer,Frederick E. Dewey,David J. Carey,VA Million Veteran Program,VA Million Veteran Program,John Concato,J. Michael Gaziano,J. Michael Gaziano,J. Michael Gaziano,Christopher J. O'Donnell,Christopher J. O'Donnell,Philip S. Tsao,Philip S. Tsao,Sekar Kathiresan,Sekar Kathiresan,Daniel J. Rader,Peter W.F. Wilson,Peter W.F. Wilson,Themistocles L. Assimes,Themistocles L. Assimes +67 more
TL;DR: Analysis of genetic data and blood lipid measurements from over 300,000 participants in the Million Veteran Program identifies new associations for blood lipid traits and proposes novel indications for pharmaceutical inhibitors targeting PCSK9, ANGPTL4 (type 2 diabetes) and PDE3B (triglycerides and coronary disease).
Journal ArticleDOI
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset.
Raphaela Goldbach-Mansky,Jennifer Lee,Angela McCoy,Joseph M. Hoxworth,Cheryl Yarboro,Josef S. Smolen,Günter Steiner,Antony Rosen,Cindy Zhang,Henri A. Ménard,Zhi Jie Zhou,Timo Palosuo,Walther J. van Venrooij,Ronald L. Wilder,John H. Klippel,H. Ralph Schumacher,Hani El-Gabalawy +16 more
TL;DR: Although these antibodies may preferentially recognize citrullinated antigens, the modest degree of concordance between them in individual patient sera suggests that it is unlikely a single antigen is involved in generating these responses.
Journal ArticleDOI
Serum 25-hydroxyvitamin D concentrations and risk for hip fractures.
Jane A. Cauley,Andrea Z. LaCroix,Lieling Wu,Mara J. Horwitz,Michelle E. Danielson,Doug C. Bauer,Jennifer Lee,Rebecca D. Jackson,John A Robbins,Chunyuan Wu,Frank Z. Stanczyk,Meryl S. LeBoff,Jean Wactawski-Wende,Gloria E. Sarto,Judith K. Ockene,Steven R. Cummings +15 more
TL;DR: Whether low serum 25(OH) vitamin D concentrations are associated with a higher risk for hip fractures in community-dwelling women and whether this relationship may be mediated by poor physical functioning, frailty, falls, sex-steroid hormones, renal function, or bone turnover is tested.
Journal ArticleDOI
Factors Related to Age at Natural Menopause: Longitudinal Analyses From SWAN
Ellen B. Gold,Sybil L. Crawford,Nancy E. Avis,Carolyn J. Crandall,Karen A. Matthews,L. Elaine Waetjen,Jennifer Lee,Rebecca C. Thurston,Marike Vuga,Siobán D. Harlow +9 more
TL;DR: Results suggest that age at the natural FMP reflects a complex interrelation of health and socioeconomic factors, which could partially explain the relation of late age at FMP to reduced morbidity and mortality.
Journal ArticleDOI
Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN).
Gail A. Greendale,MaryFran Sowers,Weijuan Han,Mei-Hua Huang,Joel S. Finkelstein,Carolyn J. Crandall,Jennifer Lee,Arun S. Karlamangla +7 more
TL;DR: Piecewise, linear, mixed‐effects regression models demonstrated that during the 10‐year observation period, at each bone site, the rates and cumulative amounts of bone loss were greatest from 1 year before through 2 years after the FMP, termed the transmenopause.